2025年全球異位性皮膚炎數位療法市場報告

近年來，異位性皮膚炎的數位療法市場發展迅速，預計將從2024年的4.7億美元成長到2025年的5.7億美元，複合年成長率達21.6%。過去幾年的成長可歸因於醫療保健領域數位化進程的不斷推進、製藥公司與科技公司之間合作的日益密切、監管部門對數位療法的支持力度加大、保險覆蓋範圍和報銷計劃的擴大，以及居家照護解決方案的日益普及。

預計未來幾年，異位性皮膚炎數位療法市場將快速成長，到2029年市場規模將達到12.4億美元，複合年成長率（CAGR）為21.3%。預測期內的成長要素包括：行動醫療應用的日益普及、對提高患者依從性和治療效果的日益重視、遠端醫療和遠端患者監護的廣泛應用、政府對數位醫療的支持力度加大以及相關法規的最佳化，以及新興經濟體市場滲透率的不斷提高。預測期內的主要趨勢包括：軟體和設備的技術進步、基於人工智慧的患者管理創新、行動醫療應用開發的快速發展、生物製藥整合方面的研發以及數位療法平台的持續改進。

預計未來幾年，智慧型手機普及率的不斷提高將推動特應性皮膚炎數位療法市場的成長。智慧型手機是一種攜帶式設備，集通訊、網路連接和運算功能於一體。其普及主要得益於網路普及率的不斷提高，使更多人能夠方便地存取線上服務、社群媒體和數位內容。智慧型手機的高普及率將促進異位性皮膚炎數位療法的發展。患者可以無縫存取行動應用程式和數位平台，從而實現即時症狀追蹤、治療提醒和個人化指導，最終提高治療依從性和疾病管理水平。例如，英國比價和切換服務供應商Uswitch Limited在2023年2月發布的報告預測，2022年英國的活躍行動連線將達到7,180萬，到2025年，英國6,830萬人口中將有95%的人擁有智慧型手機。因此，智慧型手機使用量的成長預計將推動異位性皮膚炎數位療法市場的成長。

異位性皮膚炎數位療法市場的主要企業正專注於早期投資，以促進創新和成長。這些種子輪融資不僅為Start-Ups創業公司提供資金支持，還提供導師指導、產業網路和策略支援。例如，總部位於德國的AI驅動型皮膚病成像解決方案供應商Nia Health於2023年5月宣布成功完成410萬美元（350萬歐元）的種子輪資金籌措。這項投資將使該公司能夠進一步開發其在柏林夏里特大學醫院開發的異位性皮膚炎數位療法應用程式。該資金將有助於該公司鞏固其在德語市場的地位，並在未來兩年內加速拓展至其他歐盟國家，同時為進軍美國市場做好準備。該公司還計劃加速開發其應用程式的AI驅動功能，包括機器視覺、自然語言處理和遠端皮膚科會診功能。

目錄

第1章執行摘要

第2章 市場特徵

第3章 市場趨勢與策略

第4章 市場：宏觀經濟情景，包括利率、通貨膨脹、地緣政治、貿易戰和關稅，以及新冠疫情及其復甦對市場的影響

第5章 全球成長分析與策略分析框架

• 全球異位性皮膚炎數位療法市場：PESTEL 分析（政治、社會、技術、環境、法律因素、促進因素和限制因素）
• 終端用戶產業分析
• 全球異位性皮膚炎數位療法市場：成長率分析
• 全球異位性皮膚炎數位療法市場：規模與成長，2019-2024年
• 全球異位性皮膚炎數位療法市場預測：規模與成長，2024-2029年，2034年預測
• 全球異位性皮膚炎數位療法市場：潛在市場規模 (TAM)

第6章 市場細分

• 全球異位性皮膚炎數位療法市場：依產品類型、表現和預測分類，2019-2024年、2024-2029年預測、2034年預測
• 軟體應用
• 裝置
• 平台
• 全球異位性皮膚炎數位治療藥物市場：按應用、性能和預測分類，2019-2024年、2024-2029年預測、2034年預測
• 疾病管理
• 預防醫學
• 治療支持
• 全球異位性皮膚炎數位療法市場：依最終用戶分類，結果及預測，2019-2024年、2024-2029年預測、2034年預測
• 患者
• 醫療保健提供者
• 付款人
• 其他最終用戶
• 全球異位性皮膚炎數位治療藥物市場：依通路分類，結果及預測，2019-2024年、2024-2029年預測、2034年預測
• 線上
• 離線
• 全球異位性皮膚炎數位療法市場：按軟體應用、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
• 行動應用
• Web應用程式
• 桌面應用程式
• 雲端基礎的應用
• 全球異位性皮膚炎數位療法市場：按設備、類型、性能和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
• 穿戴式裝置
• 監控設備
• 診斷設備
• 治療設備
• 全球異位性皮膚炎數位療法市場：按平台、類型、表現和預測進行細分，2019-2024年、2024-2029年預測、2034年預測
• 病患管理平台
• 臨床醫生支援平台
• 數據分析平台
• 遠端醫療平台

第7章 區域和國家分析

• 全球異位性皮膚炎數位療法市場：依地區分類，結果及預測，2019-2024年、2024-2029年預測、2034年預測
• 全球異位性皮膚炎數位療法市場：依國家分類，結果及預測，2019-2024 年、2024-2029 年預測、2034 年預測

第8章 亞太市場

第9章：中國市場

第10章 印度市場

第11章 日本市場

第12章：澳洲市場

第13章 印尼市場

第14章 韓國市場

第15章 西歐市場

第16章英國市場

第17章：德國市場

第18章：法國市場

第19章：義大利市場

第20章：西班牙市場

第21章 東歐市場

第22章 俄羅斯市場

第23章 北美市場

第24章美國市場

第25章：加拿大市場

第26章 南美洲市場

第27章：巴西市場

第28章 中東市場

第29章：非洲市場

第30章：競爭格局與公司概況

• 異位性皮膚炎數位療法市場：競爭格局
• 異位性皮膚炎數位療法市場：公司概況
  • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Sanofi Overview, Products and Services, Strategy and Financial Analysis
  • Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

第31章：其他領先和創新企業

• Otsuka Pharmaceutical Co. Ltd.
• OMRON Corporation
• Galderma SA
• Incyte Corporation
• Chugai Pharmaceutical Co. Ltd.
• Teladoc Health Inc.
• LEO Pharma A/S
• Almirall SA
• Biofourmis Inc.
• Click Therapeutics Inc.
• DarioHealth Corp.
• Sidekick Health GmbH
• Digital Diagnostics Inc.
• Liva Healthcare A/S
• 3Derm Systems

第32章 全球市場競爭基準化分析與儀錶板

第33章 重大併購

第34章 近期市場趨勢

第35章：高潛力市場國家、細分市場與策略

• 2029年異位性皮膚炎數位療法市場：提供新機會的國家
• 2029年異位性皮膚炎數位療法市場：蘊藏新機會的細分領域
• 2029年異位性皮膚炎數位療法市場：成長策略
  • 基於市場趨勢的策略
  • 競爭對手策略

第36章附錄

Digital therapeutics for atopic dermatitis are technology-based interventions that utilize clinically validated software to assist in managing the condition. These therapeutics aim to influence patient behavior and offer research-based guidance to enhance treatment adherence, symptom management, and overall skin health.

The main product types of digital therapeutics for atopic dermatitis include software applications, devices, and platforms. Software applications are digital programs developed to perform specific functions and deliver therapeutic interventions through computers or mobile devices. They are used for disease management, preventive care, and treatment support and are utilized by various end users, including patients, healthcare providers, payers, and others. The distribution channels include both online and offline modes.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The digital therapeutics for atopic dermatitis market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics for atopic dermatitis market statistics, including digital therapeutics for atopic dermatitis industry global market size, regional shares, competitors with a digital therapeutics for atopic dermatitis market share, detailed digital therapeutics for atopic dermatitis market segments, market trends and opportunities, and any further data you may need to thrive in the digital therapeutics for atopic dermatitis industry. This digital therapeutics for atopic dermatitis market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The digital therapeutics for the atopic dermatitis market size has grown exponentially in recent years. It will grow from $0.47 billion in 2024 to $0.57 billion in 2025 at a compound annual growth rate (CAGR) of 21.6%. The growth during the historic period can be attributed to increasing healthcare digitalization initiatives, expanding collaborations between pharmaceutical and technology companies, growing regulatory support for digital therapeutics, rising insurance coverage and reimbursement programs, and the increasing adoption of home-based care solutions.

The digital therapeutics for the atopic dermatitis market size is expected to see exponential growth in the next few years. It will grow to $1.24 billion in 2029 at a compound annual growth rate (CAGR) of 21.3%. The growth in the forecast period can be attributed to the rising adoption of mobile health applications, increasing focus on improving patient adherence and outcomes, growing use of telehealth and remote patient monitoring, expanding government support and favorable regulations for digital health, and increasing market penetration in emerging economies. Key trends during the forecast period include technological advancements in software and devices, innovations in AI-based patient management, progress in mobile health application development, research and development in biologics integration, and continuous improvements in digital therapeutic platforms.

The rising adoption of smartphones is expected to drive the growth of the digital therapeutics for atopic dermatitis market in the coming years. Smartphones are portable devices that combine communication, internet connectivity, and computing capabilities in one unit. Their growing adoption is primarily driven by increasing internet penetration, which enables more people to conveniently access online services, social media, and digital content. High smartphone usage supports digital therapeutics for atopic dermatitis by providing patients with seamless access to mobile applications and digital platforms that allow real-time symptom tracking, treatment reminders, and personalized guidance, ultimately improving adherence and disease management. For example, in February 2023, according to a report by Uswitch Limited, a UK-based comparison and switching service provider, there were 71.8 million active mobile connections in 2022, and by 2025, 95 percent of the 68.3 million people in the UK are expected to own smartphones. Therefore, the growing use of smartphones is anticipated to fuel the expansion of the digital therapeutics for atopic dermatitis market.

Major companies in the digital therapeutics for atopic dermatitis market are focusing on early-stage investments to foster innovation and growth. These seed funds not only provide financial backing but also mentorship, industry connections, and strategic support to emerging startups. For instance, in May 2023, Nia Health, a Germany-based provider of AI-powered dermatological imaging solutions, announced the successful completion of a $4.1 million (€3.5 million) seed funding round. This investment will help the company further develop its digital therapeutics application for atopic dermatitis, originally developed at Charite Universitatsmedizin Berlin. The funding will strengthen the company's presence in German-speaking markets, facilitate expansion into other European Union countries over the next two years, and prepare for entry into the US market. It will also accelerate advancements in the app's AI-driven features, including machine vision, natural language processing, and teledermatology functionalities.

In December 2023, Aptar Digital Health, a US-based digital health solutions provider, partnered with Legit.Health to advance immuno-dermatology care. Through this collaboration, Aptar's Digital Health platform integrates Legit.Health's advanced technology, capable of assisting in the diagnosis of nearly 300 conditions, including atopic dermatitis, psoriasis, and skin cancer. This integration aims to enhance patient care and engagement by enabling healthcare professionals to identify skin conditions earlier, allowing patients to begin treatment sooner and improve their overall quality of life. Legit.Health is a Spain-based medical software company specializing in AI-driven dermatological tools.

Major players in the digital therapeutics for atopic dermatitis market are Pfizer Inc., AbbVie Inc., Sanofi, Eli Lilly and Company, Boehringer Ingelheim International GmbH, Otsuka Pharmaceutical Co. Ltd., OMRON Corporation, Galderma S.A., Incyte Corporation, Chugai Pharmaceutical Co. Ltd., Teladoc Health Inc., LEO Pharma A/S, Almirall S.A., Biofourmis Inc., Click Therapeutics Inc., DarioHealth Corp., Sidekick Health GmbH, Digital Diagnostics Inc., Liva Healthcare A/S, and 3Derm Systems.

North America was the largest region in the digital therapeutics for atopic dermatitis market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital therapeutics for atopic dermatitis report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the digital therapeutics for atopic dermatitis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics for atopic dermatitis market consists of revenues earned by entities by providing services such as personalized treatment plans, symptom tracking, and teleconsultation support. The market value includes the value of related goods sold by the service provider or included within the service offering. the digital therapeutics for atopic dermatitis market also includes sales of smart patches, wearable sensors, skin imaging devices, and portable dermatoscopes. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics For Atopic Dermatitis Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics for atopic dermatitis market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics for atopic dermatitis ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics for atopic dermatitis market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Product Type: Software Applications; Devices; Platforms
• 2) By Application: Disease Management; Preventive Care; Treatment Support
• 3) By End-User: Patients; Healthcare Providers; Payers; Other End-Users
• 4) By Distribution Channel: Online; Offline
• Subsegments:
• 1) By Software Applications: Mobile Applications; Web Applications; Desktop Applications; Cloud-Based Applications
• 2) By Devices: Wearable Devices; Monitoring Devices; Diagnostic Devices; Therapeutic Devices
• 3) By Platforms: Patient Management Platforms; Clinician Support Platforms; Data Analytics Platforms; Telehealth Platforms
• Companies Mentioned: Pfizer Inc.; AbbVie Inc.; Sanofi; Eli Lilly and Company; Boehringer Ingelheim International GmbH; Otsuka Pharmaceutical Co. Ltd.; OMRON Corporation; Galderma S.A.; Incyte Corporation; Chugai Pharmaceutical Co. Ltd.; Teladoc Health Inc.; LEO Pharma A/S; Almirall S.A.; Biofourmis Inc.; Click Therapeutics Inc.; DarioHealth Corp.; Sidekick Health GmbH; Digital Diagnostics Inc.; Liva Healthcare A/S; 3Derm Systems.
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digital Therapeutics For Atopic Dermatitis Market Characteristics

3. Digital Therapeutics For Atopic Dermatitis Market Trends And Strategies

4. Digital Therapeutics For Atopic Dermatitis Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

• 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Therapeutics For Atopic Dermatitis Growth Analysis And Strategic Analysis Framework

• 5.1. Global Digital Therapeutics For Atopic Dermatitis PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Digital Therapeutics For Atopic Dermatitis Market Growth Rate Analysis
• 5.4. Global Digital Therapeutics For Atopic Dermatitis Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Digital Therapeutics For Atopic Dermatitis Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Digital Therapeutics For Atopic Dermatitis Total Addressable Market (TAM)

6. Digital Therapeutics For Atopic Dermatitis Market Segmentation

• 6.1. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Software Applications
• Devices
• Platforms
• 6.2. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Disease Management
• Preventive Care
• Treatment Support
• 6.3. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patients
• Healthcare Providers
• Payers
• Other End-Users
• 6.4. Global Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Online
• Offline
• 6.5. Global Digital Therapeutics For Atopic Dermatitis Market, Sub-Segmentation Of Software Applications, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Mobile Applications
• Web Applications
• Desktop Applications
• Cloud-Based Applications
• 6.6. Global Digital Therapeutics For Atopic Dermatitis Market, Sub-Segmentation Of Devices, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Wearable Devices
• Monitoring Devices
• Diagnostic Devices
• Therapeutic Devices
• 6.7. Global Digital Therapeutics For Atopic Dermatitis Market, Sub-Segmentation Of Platforms, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Patient Management Platforms
• Clinician Support Platforms
• Data Analytics Platforms
• Telehealth Platforms

7. Digital Therapeutics For Atopic Dermatitis Market Regional And Country Analysis

• 7.1. Global Digital Therapeutics For Atopic Dermatitis Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Digital Therapeutics For Atopic Dermatitis Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market

• 8.1. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Therapeutics For Atopic Dermatitis Market

• 9.1. China Digital Therapeutics For Atopic Dermatitis Market Overview
• 9.2. China Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Therapeutics For Atopic Dermatitis Market

• 10.1. India Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Therapeutics For Atopic Dermatitis Market

• 11.1. Japan Digital Therapeutics For Atopic Dermatitis Market Overview
• 11.2. Japan Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Therapeutics For Atopic Dermatitis Market

• 12.1. Australia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Therapeutics For Atopic Dermatitis Market

• 13.1. Indonesia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Therapeutics For Atopic Dermatitis Market

• 14.1. South Korea Digital Therapeutics For Atopic Dermatitis Market Overview
• 14.2. South Korea Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Therapeutics For Atopic Dermatitis Market

• 15.1. Western Europe Digital Therapeutics For Atopic Dermatitis Market Overview
• 15.2. Western Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Therapeutics For Atopic Dermatitis Market

• 16.1. UK Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Therapeutics For Atopic Dermatitis Market

• 17.1. Germany Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Therapeutics For Atopic Dermatitis Market

• 18.1. France Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Therapeutics For Atopic Dermatitis Market

• 19.1. Italy Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Therapeutics For Atopic Dermatitis Market

• 20.1. Spain Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market

• 21.1. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market Overview
• 21.2. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Therapeutics For Atopic Dermatitis Market

• 22.1. Russia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Therapeutics For Atopic Dermatitis Market

• 23.1. North America Digital Therapeutics For Atopic Dermatitis Market Overview
• 23.2. North America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Therapeutics For Atopic Dermatitis Market

• 24.1. USA Digital Therapeutics For Atopic Dermatitis Market Overview
• 24.2. USA Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Therapeutics For Atopic Dermatitis Market

• 25.1. Canada Digital Therapeutics For Atopic Dermatitis Market Overview
• 25.2. Canada Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Therapeutics For Atopic Dermatitis Market

• 26.1. South America Digital Therapeutics For Atopic Dermatitis Market Overview
• 26.2. South America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Therapeutics For Atopic Dermatitis Market

• 27.1. Brazil Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Therapeutics For Atopic Dermatitis Market

• 28.1. Middle East Digital Therapeutics For Atopic Dermatitis Market Overview
• 28.2. Middle East Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Therapeutics For Atopic Dermatitis Market

• 29.1. Africa Digital Therapeutics For Atopic Dermatitis Market Overview
• 29.2. Africa Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Digital Therapeutics For Atopic Dermatitis Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Digital Therapeutics For Atopic Dermatitis Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Therapeutics For Atopic Dermatitis Market Competitive Landscape And Company Profiles

• 30.1. Digital Therapeutics For Atopic Dermatitis Market Competitive Landscape
• 30.2. Digital Therapeutics For Atopic Dermatitis Market Company Profiles
  • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. AbbVie Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Sanofi Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Eli Lilly and Company Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Boehringer Ingelheim International GmbH Overview, Products and Services, Strategy and Financial Analysis

31. Digital Therapeutics For Atopic Dermatitis Market Other Major And Innovative Companies

• 31.1. Otsuka Pharmaceutical Co. Ltd.
• 31.2. OMRON Corporation
• 31.3. Galderma S.A.
• 31.4. Incyte Corporation
• 31.5. Chugai Pharmaceutical Co. Ltd.
• 31.6. Teladoc Health Inc.
• 31.7. LEO Pharma A/S
• 31.8. Almirall S.A.
• 31.9. Biofourmis Inc.
• 31.10. Click Therapeutics Inc.
• 31.11. DarioHealth Corp.
• 31.12. Sidekick Health GmbH
• 31.13. Digital Diagnostics Inc.
• 31.14. Liva Healthcare A/S
• 31.15. 3Derm Systems

32. Global Digital Therapeutics For Atopic Dermatitis Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics For Atopic Dermatitis Market

34. Recent Developments In The Digital Therapeutics For Atopic Dermatitis Market

35. Digital Therapeutics For Atopic Dermatitis Market High Potential Countries, Segments and Strategies

• 35.1 Digital Therapeutics For Atopic Dermatitis Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Digital Therapeutics For Atopic Dermatitis Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Digital Therapeutics For Atopic Dermatitis Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer